自协同 RNA 疫苗减轻树突状细胞介导的获得性免疫抵抗以增强细胞疗法对实体瘤的疗效 Self-Cooperative RNA Vaccine Mitigates Dendritic Cell-Mediated Acquired Immune Resistance to Potentiate Cell Therapy for Solid Tumors. PubMed 2026/07/09 发表Adv MaterQ1 · IF 29.1(JCR 2025) 技术:TIL技术:mRNA肝细胞癌黑色素瘤地区:中国